《A novel series of potent and selective ketone histone deacetylase inhibitors with antitumor activity in vivo》 was written by Jones, Philip; Altamura, Sergio; De Francesco, Raffaele; Gonzalez Paz, Odalys; Kinzel, Olaf; Mesiti, Giuseppe; Monteagudo, Edith; Pescatore, Giovanna; Rowley, Michael; Verdirame, Maria; Steinkuhler, Christian. Reference of 1-Methylpiperidine-2-carboxylic acid hydrochloride And the article was included in Journal of Medicinal Chemistry on April 24 ,2008. The article conveys some information:
Histone deacetylase (HDAC) inhibitors offer a promising strategy for cancer therapy, and the first generation HDAC inhibitors are currently in the clinic. Entirely novel ketone HDAC inhibitors have been developed from the cyclic tetrapeptide apicidin. These compounds show class I subtype selectivity and levels of cellular activity comparable to clin. candidates. A representative example has demonstrated tumor growth inhibition in a human colon HCT-116 carcinoma xenograft model comparable to known inhibitors. The experimental process involved the reaction of 1-Methylpiperidine-2-carboxylic acid hydrochloride(cas: 25271-35-6Reference of 1-Methylpiperidine-2-carboxylic acid hydrochloride)
1-Methylpiperidine-2-carboxylic acid hydrochloride(cas: 25271-35-6) is a member of piperidine. Piperidine-containing compounds are also frequently employed in synthesis as ligands or auxiliaries. Accordingly, many efforts have been devoted to the development of novel methods for the synthesis of these compounds over the years.Reference of 1-Methylpiperidine-2-carboxylic acid hydrochloride
Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem